Researchers report that TAK-243, a first-in-class ubiquitin activating enzyme UBA1 inhibitor in clinical development, caused preferential cytotoxicity in SLFN11-knock out cells.
[Cancer Research]
6445212 {6445212:32VIIQHK} apa 50 1 161307 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5e7293968ac593e84719d283dea28e1f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2232VIIQHK%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murai%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMurai%2C%20Y.%2C%20Jo%2C%20U.%2C%20Murai%2C%20J.%2C%20Jenkins%2C%20L.%2C%20Huang%2C%20S.-Y.%20N.%2C%20Chakka%2C%20S.%2C%20Chen%2C%20L.%2C%20Cheng%2C%20K.%2C%20Fukuda%2C%20S.%2C%20Takebe%2C%20N.%2C%20%26amp%3B%20Pommier%2C%20Y.%20%282021%29.%20SLFN11%20inactivation%20induces%20proteotoxic%20stress%20and%20sensitizes%20cancer%20cells%20to%20ubiquitin%20activating%20enzyme%20inhibitor%20TAK-243.%20%3Ci%3ECancer%20Research%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F0008-5472.CAN-20-2694%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F0008-5472.CAN-20-2694%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D32VIIQHK%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SLFN11%20inactivation%20induces%20proteotoxic%20stress%20and%20sensitizes%20cancer%20cells%20to%20ubiquitin%20activating%20enzyme%20inhibitor%20TAK-243%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuhisa%22%2C%22lastName%22%3A%22Murai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ukhyun%22%2C%22lastName%22%3A%22Jo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junko%22%2C%22lastName%22%3A%22Murai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shar-Yin%20N.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sirisha%22%2C%22lastName%22%3A%22Chakka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lu%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ken%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shinsaku%22%2C%22lastName%22%3A%22Fukuda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naoko%22%2C%22lastName%22%3A%22Takebe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22Pommier%22%7D%5D%2C%22abstractNote%22%3A%22Schlafen11%20%28SLFN11%29%20inactivation%20occurs%20in%20approximately%2050%25%20of%20cancer%20cell%20lines%20and%20in%20a%20large%20fraction%20of%20patient%20tumor%20samples%2C%20which%20leads%20to%20chemoresistance.%20Therefore%2C%20new%20therapeutic%20approaches%20are%20needed%20to%20target%20SLFN11-deficient%20cancers.%20To%20that%20effect%2C%20we%20conducted%20a%20drug%20screen%20with%20the%20NCATS%20mechanistic%20drug%20library%20of%201978%20compounds%20in%20isogenic%20SLFN11-knockout%20%28KO%29%20and%20wild-type%20%28WT%29%20leukemia%20cell%20lines.%20Here%20we%20report%20that%20TAK-243%2C%20a%20first-in-class%20ubiquitin%20activating%20enzyme%20UBA1%20inhibitor%20in%20clinical%20development%2C%20causes%20preferential%20cytotoxicity%20in%20SLFN11-KO%20cells%3B%20this%20effect%20is%20associated%20with%20claspin-mediated%20DNA%20replication%20inhibition%20by%20CHK1%20independently%20of%20ATR.%20Additional%20analyses%20showed%20that%20SLFN11-KO%20cells%20exhibit%20consistently%20enhanced%20global%20protein%20ubiquitylation%2C%20endoplasmic%20reticulum%20%28ER%29%20stress%2C%20unfolded%20protein%20response%20%28UPR%29%2C%20and%20protein%20aggregation.%20TAK-243%20suppressed%20global%20protein%20ubiquitylation%20and%20activated%20the%20UPR%20transducers%20PERK%2C%20phosphorylated%20eIF2alpha%2C%20phosphorylated%20IRE1%2C%20and%20ATF6%20more%20effectively%20in%20SLFN11-KO%20cells%20than%20WT%20cells.%20Proteomic%20analysis%20using%20biotinylated%20mass%20spectrometry%20and%20RNAi%20screening%20also%20showed%20physical%20and%20functional%20interactions%20of%20SLFN11%20with%20translation%20initiation%20complexes%20and%20protein%20folding%20machinery.%20These%20findings%20uncover%20a%20previously%20unknown%20function%20of%20SLFN11%20as%20a%20regulator%20of%20protein%20quality%20control%20and%20attenuator%20of%20ER%20stress%20and%20UPR.%20Moreover%2C%20they%20suggest%20the%20potential%20value%20of%20TAK-243%20in%20SLFN11-deficient%20tumors.%22%2C%22date%22%3A%222021%5C%2F01%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-20-2694%22%2C%22ISSN%22%3A%220008-5472%2C%201538-7445%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fcancerres.aacrjournals.org%5C%2Fcontent%5C%2Fearly%5C%2F2021%5C%2F04%5C%2F16%5C%2F0008-5472.CAN-20-2694%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-19T17%3A42%3A17Z%22%7D%7D%5D%7D
Murai, Y., Jo, U., Murai, J., Jenkins, L., Huang, S.-Y. N., Chakka, S., Chen, L., Cheng, K., Fukuda, S., Takebe, N., & Pommier, Y. (2021). SLFN11 inactivation induces proteotoxic stress and sensitizes cancer cells to ubiquitin activating enzyme inhibitor TAK-243. Cancer Research. https://doi.org/10.1158/0008-5472.CAN-20-2694 Cite